As the work force returns to the office, life science companies are having to take their stance on vaccine policy. Some have chosen a strict mandate, others a mandate with options, and others have yet to issue an edict.
Leading scientists, public policy experts and biotech industry leaders joined forces to launch “Working to Fight AMR,” a coalition working to raise public awareness of the growing threat posed by antimicrobial resistance.